Department of Urology, King's College Hospital, London, UK.
BJU Int. 2012 Dec;110(11):1590-4. doi: 10.1111/j.1464-410X.2012.11101.x. Epub 2012 Mar 27.
What's known on the subject? and What does the study add? Chronic urinary retention (CUR) is a poorly defined entity, as the key element of definition, significant postvoid residual urine volume (PVR), has not a worldwide and moreover evidenced-based definition. There is no agreement on which is the threshold value to define a significant PVR and different society produced guidelines with different thresholds ranging from 300 mL to 1000 mL. Diagnosis is difficult, and management has not been defined yet. There is a lack of studies on the best management of these patients, as this group of patients has always been considered at high risk of failure. Only one study compares conservative with the surgical management but it is not a randomised controlled trail. This review offers a systematic appraisal of the most recent publications on CUR. It indicates the absence of a real worldwide agreed definition, as the two keys element of it are not satisfactorily defined yet: significant PVR, is suffering from a lack of evidenced-based definition, and percussable or palpable bladder is a very nebulous concept as it is not a criteria of certainty as different individual variables affect it. This has an important effect on management which is not structured. Most of the trials involving benign prostatic hyperplasia treatments (either medical or surgical) tend to exclude this group of patients, which is a clinically important group, comprising up to a quarter of men undergoing TURP in the UK. Urinary retention describes a bladder that does not empty completely or does not empty at all. Historically, urinary retention has been classified as either acute or chronic the latter is generally classified as high pressure or low pressure according to the bladder filling pressure on urodynamic. A MEDLINE® search for articles written in English and published before January 2010 was done using a list of terms related to urinary retention: 'urinary retention', 'chronic urinary retention' and 'PVR'. Chronic urinary retention (CUR) is defined by the International Continence Society as 'a non-painful bladder, which remains palpable or percussable after the patient has passed urine'. Abrams was the first to choose a residual urine volume >300 mL to define CUR as he considered it the minimum volume at which the bladder becomes palpable suprapubically. The UK National Institute for Health and Clinical Excellence lower urinary tract symptoms (LUTS) guidelines define CUR as a postvoid residual urine volume (PVR) of >1000 mL. No studies have specifically addressed the problem of quantifying the minimum amount of urine present in the bladder to define CUR. Nor did we find any publications objectively assessing at what amount of urine a bladder can be palpable. The ability to feel a bladder may rely on variables (i.e. medical skills and patient habitus). There is a marked variability of PVR, so the test should be repeated to improve precision. As defining CUR is difficult, structured management is challenging. Nearly all prospective trials exclude men with CUR from analysis, possibly anticipating a poor outcome and a high risk of complications. However, men with CUR are a clinically important group, comprising up to 25% of men undergoing transurethral resection of the prostate. Definition of CUR is imprecise and arbitrary. Most studies seem to describe the condition as either a PVR of >300 mL in men who are voiding, or >1000 mL in men who are unable to void. This confusion leads to an inability to design and interpret studies; indeed most prospective trials simply exclude these patients. There is a clear need for internationally accepted definitions of retention to allow both treatment and reporting of outcomes in men with LUTS, and for such definitions to be used by all investigators in future trials.
关于这个主题已知的内容是什么?这项研究增加了什么?慢性尿潴留(CUR)是一个定义不明确的实体,因为定义的关键要素,即显著的剩余尿量(PVR),尚未在全球范围内得到证据支持的定义。目前尚无关于定义显著 PVR 的阈值的共识,不同的社会制定了不同的指南,阈值范围从 300 毫升到 1000 毫升不等。诊断困难,管理尚未确定。对于这些患者的最佳管理缺乏研究,因为这群患者一直被认为是高失败风险的。只有一项研究比较了保守治疗和手术治疗,但它不是随机对照试验。本综述对 CUR 的最新出版物进行了系统评价。它表明,目前还没有一个真正的全球公认的定义,因为其两个关键要素尚未得到令人满意的定义:显著的 PVR,缺乏基于证据的定义,可触诊或可触及的膀胱是一个非常模糊的概念,因为它不是确定性的标准,因为不同的个体变量会影响它。这对没有结构的管理产生了重要影响。涉及良性前列腺增生治疗(无论是药物治疗还是手术治疗)的大多数试验往往排除了这群患者,这群患者是一个具有重要临床意义的群体,占英国接受 TURP 治疗的男性的四分之一。尿潴留描述的是膀胱不能完全排空或根本不能排空的情况。从历史上看,尿潴留分为急性和慢性,后者根据尿动力学上的膀胱充盈压一般分为高压或低压。使用与尿潴留相关的术语列表在 2010 年 1 月之前以英文发表的文章进行了 MEDLINE®搜索:“尿潴留”,“慢性尿潴留”和“PVR”。国际尿控协会将慢性尿潴留(CUR)定义为“非疼痛性膀胱,在患者排尿后仍可触及或可触及”。Abrams 是第一个选择残余尿量>300 毫升来定义 CUR 的人,因为他认为这是膀胱变得可触诊耻骨上的最小体积。英国国家卫生与临床优化研究所下尿路症状(LUTS)指南将 CUR 定义为残余尿量(PVR)>1000 毫升。没有研究专门解决定量膀胱中存在的尿液量以定义 CUR 的问题。我们也没有发现任何出版物客观地评估膀胱中可以触及多少尿液。感觉到膀胱的能力可能依赖于变量(即医疗技能和患者体型)。PVR 变化很大,因此应重复测试以提高精度。由于 CUR 的定义很困难,因此结构化管理具有挑战性。几乎所有前瞻性试验都将有 CUR 的男性排除在分析之外,可能是因为预期预后不佳和并发症风险高。然而,有 CUR 的男性是一个具有重要临床意义的群体,占英国接受经尿道前列腺切除术的男性的 25%。CUR 的定义不精确且任意。大多数研究似乎将 PVR>300 毫升的男性描述为有能力排尿的患者,或 PVR>1000 毫升的无法排尿的男性。这种混淆导致无法设计和解释研究;事实上,大多数前瞻性试验只是将这些患者排除在外。迫切需要国际公认的保留定义,以便在有 LUTS 的男性中进行治疗和报告结果,并让所有研究人员在未来的试验中使用这些定义。